While revenue and profit figures are not disclosed, GENDA and LDH JAPAN have decided to establish a joint venture named ‘Tokyo DD Co., Ltd.’ Capital partnership is 50:50, with planned establishment date of August 14. GENDA and LDH JAPAN will hold 50% each, and AGBIOTECH will hold 1.0% non-voting shares. Business scope includes IP planning and development.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9166","jir_company_name":"GenDA Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/9166-20260805-01.pdf","jir_short_summary":"While revenue and profit figures are not disclosed, GENDA and LDH JAPAN have decided to establish a joint venture named 'Tokyo DD Co., Ltd.' Capital partnership is 50:50, with planned establishment date of August 14. GENDA and LDH JAPAN will hold 50% each, and AGBIOTECH will hold 1.0% non-voting shares. Business scope includes IP planning and development.","jir_summary":"### Overview of this matter\nGENDA and LDH JAPAN will leverage IP planning capability and content creation power to jointly plan and develop new IP, establishing a joint venture named 'Tokyo DD Co., Ltd.' The venture aims for global market expansion by integrating upstream and downstream in the entertainment domain, centering on IP. Koji Hoshino is planned to assume the position of representative director.\n\n### Financials \/ Investment \/ Outlook\nCapital stock is 50 million yen, shareholding ratio is GENDA 50.0% and LDH JAPAN 50.0%, AGBIOTECH to hold 1.0% non-voting shares. Establishment is on August 14, 2026, with a board decision date of August 5, 2026. Earnings outlook is currently undecided; financial impact is expected to be minor, with further updates to be announced as information is disclosed.","jir_financial_highlights":"Capital stock: 50 \u767e\u4e07\u5186 (Unknown)\nShareholding ratio (voting rights included): GENDA 50.0%, LDH JAPAN 50.0%, AGBIOTECH 1.0% (non-voting) (Unknown)\nEstablishment date: 2026 \u5e748\u6708 14 \u65e5 (Unknown)","jir_category":"","jir_hashtags":"#GENDA, #JointVenture, #TokyoDD, #Entertainment","jir_key_figures":"Capital stock: 50 \u767e\u4e07\u5186\nShareholding ratio: GENDA 50.0%\u3001LDH JAPAN 50.0%\u3001AGBIOTECH 1.0%\uff08\u975e\u8b70\u6c7a\u6a29\u682a\u5f0f\uff09\nEstablishment date: 2026 \u5e748\u670814\u65e5","jir_meta_title":"\u3010GENDA\u3011 Announcement of Joint Venture Establishment\uff5cTokyo DD Establishment Schedule \/ Capital Structure","jir_meta_description":"GENDA and LDH JAPAN establish a joint venture. Capital stock 50 \u767e\u4e07\u5186, shareholding ratio 50:50, establishment date planned for 8\/14. Financial impact is undecided, but new IP development framework is strengthened.","jir_og_title":"\u3010GENDA\u3011 Announcement of Joint Venture Establishment\uff5cStrengthening New IP Creation Framework","jir_og_description":"GENDA and LDH JAPAN establish a joint venture. 50:50 ownership, establishment date planned for August 14. Aiming for global expansion through new IP development.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9398,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"m_and_a_alliance","footnotes":""},"sector":[],"importance":[],"class_list":["post-95614","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n